LTO1 and hepatocellular carcinoma: Based on these results, a ceRNA regulatory axis was proposed: AC005332.1 and AC012615.1/hsa-miR-100-5p/ORAOV1, which may contribute to ORAOV1 upregulation and unfavorable prognosis in HCC (Fig. 3K).